US Stock IR Daily – June 25, 2026 (2 reports)

• On June 25, 2026, FedEx Corporation announced the commencement of cash tender offers to purchase up to $4.15 billion aggregate purchase price, not including accrued and unpaid interest, of its outstanding notes.
• The offers target 19 series of notes, including 4.500% Notes due 2065, 3.250% Notes due 2041, and various others.
• The Early Tender Time is scheduled for 5:00 p.m., New York City time, on July 9, 2026. Holders who validly tender and do not validly withdraw their notes by this deadline will receive a total consideration, which includes an early tender premium of $30 per $1,000 principal amount of notes.
• The offers are scheduled to expire at 5:00 p.m., New York City time, on July 24, 2026, unless extended or earlier terminated by the company.
• Notes validly tendered may not be validly withdrawn after 5:00 p.m., New York City time, on July 9, 2026, unless such deadline is extended.

FedEx’s cash tender offers for a substantial amount of its outstanding notes may suggest a proactive approach to debt management. The inclusion of an early tender premium is a common strategy to incentivize noteholders to participate promptly. This move could indicate the company’s efforts to optimize its debt structure and potentially manage future interest expenses on its balance sheet.

• On June 25, 2026, American Express Company issued a press release announcing the results of its company-run 2026 Dodd-Frank Act Stress Test (DFAST).
• This disclosure was made under Item 7.01 Regulation FD Disclosure of Form 8-K.
• The press release is attached as Exhibit 99.1 to the Current Report on Form 8-K and incorporated herein by reference.
• The company-run DFAST results are available on the company’s Investor Relations website at ir.americanexpress.com.

This announcement indicates that American Express has fulfilled a regulatory requirement by disclosing the results of its Dodd-Frank Act Stress Test. Stress tests like DFAST are designed to assess the resilience of financial institutions under adverse economic conditions, and the public release of these results provides transparency into the company’s financial health and risk management capabilities. Investors may view this as an update on the company’s adherence to financial stability regulations.